161 related articles for article (PubMed ID: 16327324)
1. Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas.
Friedman SR; Cooper HL; Tempalski B; Keem M; Friedman R; Flom PL; Des Jarlais DC
AIDS; 2006 Jan; 20(1):93-9. PubMed ID: 16327324
[TBL] [Abstract][Full Text] [Related]
2. The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City.
Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Heckathorn DD; Mcknight C; Bramson H; Friedman SR
Addiction; 2007 May; 102(5):778-85. PubMed ID: 17506155
[TBL] [Abstract][Full Text] [Related]
3. Demographic, HIV risk behavior, and health status characteristics of "crack" cocaine injectors compared to other injection drug users in three New England cities.
Buchanan D; Tooze JA; Shaw S; Kinzly M; Heimer R; Singer M
Drug Alcohol Depend; 2006 Feb; 81(3):221-9. PubMed ID: 16171952
[TBL] [Abstract][Full Text] [Related]
4. HIV among injection drug users in large US metropolitan areas, 1998.
Friedman SR; Lieb S; Tempalski B; Cooper H; Keem M; Friedman R; Flom PL
J Urban Health; 2005 Sep; 82(3):434-45. PubMed ID: 16014877
[TBL] [Abstract][Full Text] [Related]
5. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Abdul-Quader A; Heckathorn DD; McKnight C; Bramson H; Nemeth C; Torian LV; Friedman SR
AIDS; 2007 Jan; 21(2):231-5. PubMed ID: 17197815
[TBL] [Abstract][Full Text] [Related]
6. Predictors of the degree of drug treatment coverage for injection drug users in 94 metropolitan areas in the United States of America.
Friedman SR; Tempalski B; Brady JE; Friedman JJ; Cooper HL; Flom PL; McGrath MM; Gostnell K; Des Jarlais DC
Int J Drug Policy; 2007 Dec; 18(6):475-85. PubMed ID: 18061873
[TBL] [Abstract][Full Text] [Related]
7. Drug arrests and injection drug deterrence.
Friedman SR; Pouget ER; Chatterjee S; Cleland CM; Tempalski B; Brady JE; Cooper HL
Am J Public Health; 2011 Feb; 101(2):344-9. PubMed ID: 21164088
[TBL] [Abstract][Full Text] [Related]
8. Role of drug injection in the spread of HIV in Argentina and Brazil.
Libonatti O; Lima E; Peruga A; González R; Zacarías F; Weissenbacher M
Int J STD AIDS; 1993; 4(3):135-41. PubMed ID: 8324042
[TBL] [Abstract][Full Text] [Related]
9. Income inequality, drug-related arrests, and the health of people who inject drugs: Reflections on seventeen years of research.
Friedman SR; Tempalski B; Brady JE; West BS; Pouget ER; Williams LD; Des Jarlais DC; Cooper HL
Int J Drug Policy; 2016 Jun; 32():11-6. PubMed ID: 27198555
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of drug injection behaviors and HIV infection. National AIDS Research Consortium.
Zhuo Z; Williams M; Bell D
Int J Addict; 1994 Oct; 29(12):1499-518. PubMed ID: 7836016
[TBL] [Abstract][Full Text] [Related]
11. Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users.
Friedman SR; Tempalski B; Cooper H; Perlis T; Keem M; Friedman R; Flom PL
J Urban Health; 2004 Sep; 81(3):377-400. PubMed ID: 15273263
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for HIV-1 seroprevalence among drug injectors in the cocaine-using environment of Rio de Janeiro.
Lima ES; Friedman SR; Bastos FI; Telles PR; Friedmann P; Ward TP; des Jarlais DC
Addiction; 1994 Jun; 89(6):689-98. PubMed ID: 8069170
[TBL] [Abstract][Full Text] [Related]
13. [The prevalence of human immunodeficiency virus infection and the risk behaviors in the heroin addicts of Barcelona, Madrid and Seville: an example of the advantages of centering studies on addicts and not just on intravenous users].
de la Fuente L; Bravo MJ; Lew C; Barrio G; Soriano V; Royuela L
Med Clin (Barc); 1999 Nov; 113(17):646-51. PubMed ID: 10618778
[TBL] [Abstract][Full Text] [Related]
14. HIV seroconversion in intravenous drug users in San Francisco, 1985-1990.
Moss AR; Vranizan K; Gorter R; Bacchetti P; Watters J; Osmond D
AIDS; 1994 Feb; 8(2):223-31. PubMed ID: 8043227
[TBL] [Abstract][Full Text] [Related]
15. Drug use patterns among Thai illicit drug injectors amidst increased police presence.
Werb D; Hayashi K; Fairbairn N; Kaplan K; Suwannawong P; Lai C; Kerr T
Subst Abuse Treat Prev Policy; 2009 Jul; 4():16. PubMed ID: 19622171
[TBL] [Abstract][Full Text] [Related]
16. An international comparative study of HIV prevalence and risk behaviour among drug injectors in 13 cities. WHO Collaborative Study Group.
Bull Narc; 1993; 45(1):19-46. PubMed ID: 8305904
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. The National AIDS Research Consortium.
Friedman SR; Jose B; Deren S; Des Jarlais DC; Neaigus A
Am J Epidemiol; 1995 Oct; 142(8):864-74. PubMed ID: 7572963
[TBL] [Abstract][Full Text] [Related]
18. Drug injectors in Glasgow: a community at risk? A report from a multidisciplinary group. The Possilpark Group.
Health Bull (Edinb); 1993 Nov; 51(6):418-29. PubMed ID: 8307755
[TBL] [Abstract][Full Text] [Related]
19. New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1.
Anthony JC; Vlahov D; Nelson KE; Cohn S; Astemborski J; Solomon L
Am J Epidemiol; 1991 Nov; 134(10):1175-89. PubMed ID: 1746528
[TBL] [Abstract][Full Text] [Related]
20. Incidence and determinants of initiation into cocaine injection and correlates of frequent cocaine injectors.
Lloyd-Smith E; Wood E; Li K; Montaner JS; Kerr T
Drug Alcohol Depend; 2009 Jan; 99(1-3):176-82. PubMed ID: 18805655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
